SlideShare a Scribd company logo
1 of 26
STRUCTURE ACTIVITY
RELATIONSHIP
Abdul Samad
Dr. Syed Badshah
1
 Structure
 Activity
 SAR (Discussion/Elaboration)
Contents
2
3
Crude drug Structure Ligand bindingReceptor
Biological
response
4
CHEMICAL STRUCTURE
 A chemical structure includes molecular geometry,
electronic structure, and crystal structure of a molecule.
BIOLOGICALACTIVITY
 Biological activity is an expression describing the beneficial
or adverse effects of a drug on living matter.
5
STRUCTURE ACTIVITY RELATIONSHIP
 The relationship between the chemical or 3D
structure of a molecule and its biological activity.
Enables the determination of the chemical groups
responsible for evoking a target biological effect in
the organism.
6
WHY SAR Exist?
• The interaction of the drug molecule with protein depends
on its chemical structure
NEED OF SAR STUDY
• A study of the structure–activity relationship is mainly
done by lead molecule.
• It is used to determine pharmacophore, unwanted side
effects
• To develop a new drug that has increased activity.
7
Cont.…..
• To determine some different activity from an
existing drug
• To fewer unwanted side effects
• To know the changes in pharmacological properties
by performing minor changes in the drug molecule
8
SAR (DISCUSSION/ELABORATION)
FFFFFFFFFFFFFFFFFollowing
cALKALOIDSCFLAVONOIDS TERPENOIDS
9
TAXOL CPT
10
Camptothecin
(CPT)
WALL & WANI in
early Sixties
Camptotheca
cuminata,Tree of
Joy, Love
Quinolino
alkaloid
Pentacyclic
ring
structure
11
STRUCTURE OF CPT WITH IUPAC
NAME
12
A B C
D
E
Rings A–D are essential for activity. Saturation of ring B< activity
necessary for activity
essential for activity, S N
inactive
D-ring pyridone is required for anti
tumor activity.
 Modifications in rings A, B are well tolerated
The stereochemistry at C-20 is very crucial as
20(S) hydroxyl is active, 20(R) inactive
modifications at the C , D rings led
to complete loss of cytotoxicity.
13
Modification in rings A,B
Topotecan
Irinotecan
14
Modification in rings C,D
 In general, modifications at the C and D rings of
camptothecin led to complete loss of cytotoxicity.
 If we see these rings, the only positions available
for modifications are C-5, C-14 and C-17. Several
derivatives have been reported either with less
activity or with loss of activity.
15
Modification in ring E
 The α- hydroxyl lactone system of ring E has been
found to be important for the inhibition of the
topoisomerase enzyme as well as for in vivo
potency
 Derivatives having a lactam group instead of a
lactone, were devoid of topoisomerase inhibitor
activity.
16
17
TAXOL
Taxol, paclitaxel, trade name taxol,
by Dr. WALL and Dr. WANI
Complex
polyoxygenated
diterpenoid
Pacific yew, Taxus
brevifolia
basic [9.3.1.0]
Pentadecane, tetracyclic
ring system.
N-benzoyl-b-phenyl
isoserine side chain, at
the C-13 hydroxyl as an
ester linkage.
18
STRUCTURE OF TAXOL WITH IUPAC NAME
19
Oxitane ring essential
Ester, Amino
ester,epimer,deoxy =
active
Reduction enhance activity
Removal of acetyl < activity
Phenyl isoserine chain essential for activity
N-acyl group, required
Aryl group, essential
Free OH active in both(in vivo, in vitro)
Ester only in vivo
The C-3’aryl group is required for better
activity, methyl group, activity is reduced19-
fold.
northern and southern hemispheres.
modifications in the southern hemisphere are strictly forbidden
while in the northern hemisphere are allowed
20
C-13 SIDE CHAIN
 C-13 side chain is essentially required for anticancer
activity. The C-2’-hydroxyl is important for activity.
 When this hydroxyl is protected, activity is reduced to a
great extent and if the protection is made with a labile
group it shows similar activity in vivo, while no activity is
shown in in vitro testing
21
FLAVONOIDS
QUERCETIN
22
23
The main structural features of flavonoids required for
efficient radical scavenging could be summarized as
i. An ortho-dihydroxy (catechol) structure in the B
ring, for electron delocalization
24
 2,3-double bond in conjugation with a 4-oxo function in
the C ring provides electron delocalization from the B ring
25
 Hydroxyl groups at positions 3 and 5 provide hydrogen
bonding to the Oxo group
26
THANK YOU

More Related Content

What's hot

What's hot (20)

Structure activity relationship main
Structure activity relationship mainStructure activity relationship main
Structure activity relationship main
 
Stereochemistry&drug action- mounika.perli
Stereochemistry&drug action- mounika.perliStereochemistry&drug action- mounika.perli
Stereochemistry&drug action- mounika.perli
 
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
 
Qsar
QsarQsar
Qsar
 
Hammett parameters
Hammett parametersHammett parameters
Hammett parameters
 
Peptidomimetics
PeptidomimeticsPeptidomimetics
Peptidomimetics
 
Qsar by hansch analysis
Qsar by hansch analysisQsar by hansch analysis
Qsar by hansch analysis
 
Bioisosterism - Introduction
Bioisosterism - IntroductionBioisosterism - Introduction
Bioisosterism - Introduction
 
Role of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agentRole of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agent
 
Lead drug discovery
Lead drug discoveryLead drug discovery
Lead drug discovery
 
Prodrug strategy
Prodrug strategyProdrug strategy
Prodrug strategy
 
Drug receptor intraction
Drug receptor intractionDrug receptor intraction
Drug receptor intraction
 
Prodrug Design
Prodrug DesignProdrug Design
Prodrug Design
 
Qsar
QsarQsar
Qsar
 
Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)
 
Presentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screeningPresentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screening
 
Validation & Diversity of drug targets
Validation & Diversity of drug targetsValidation & Diversity of drug targets
Validation & Diversity of drug targets
 
Revising the Topliss Decision Tree
Revising the Topliss Decision TreeRevising the Topliss Decision Tree
Revising the Topliss Decision Tree
 
Prodrug
ProdrugProdrug
Prodrug
 
Rationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration ofRationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration of
 

Similar to Structure activity relationship 6

BMCL_2006_LSmithII
BMCL_2006_LSmithIIBMCL_2006_LSmithII
BMCL_2006_LSmithII
Leon Smith
 
Polyalkoxybenzenes JMC2011
Polyalkoxybenzenes JMC2011Polyalkoxybenzenes JMC2011
Polyalkoxybenzenes JMC2011
Alex Kiselyov
 
ASBMB Poster_16April2014_Draft5
ASBMB Poster_16April2014_Draft5ASBMB Poster_16April2014_Draft5
ASBMB Poster_16April2014_Draft5
Kaitlin Hart
 

Similar to Structure activity relationship 6 (20)

analog design.pptx
analog design.pptxanalog design.pptx
analog design.pptx
 
DR. THIRUMALAI Unit_I_3_leadOptimization.ppt
DR. THIRUMALAI Unit_I_3_leadOptimization.pptDR. THIRUMALAI Unit_I_3_leadOptimization.ppt
DR. THIRUMALAI Unit_I_3_leadOptimization.ppt
 
PEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES
PEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCESPEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES
PEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES
 
Rational Drug design
Rational Drug designRational Drug design
Rational Drug design
 
Scaffold hopping in drug development ppt
Scaffold hopping in drug development  pptScaffold hopping in drug development  ppt
Scaffold hopping in drug development ppt
 
ANALOG DESIGN.pdf
ANALOG DESIGN.pdfANALOG DESIGN.pdf
ANALOG DESIGN.pdf
 
Drug design
Drug designDrug design
Drug design
 
BMCL_2006_LSmithII
BMCL_2006_LSmithIIBMCL_2006_LSmithII
BMCL_2006_LSmithII
 
DRUG-DESIGN.docx
DRUG-DESIGN.docxDRUG-DESIGN.docx
DRUG-DESIGN.docx
 
Polyalkoxybenzenes JMC2011
Polyalkoxybenzenes JMC2011Polyalkoxybenzenes JMC2011
Polyalkoxybenzenes JMC2011
 
Ezetimibe and Other Beta Lactams SAR Degradation.pptx
Ezetimibe and Other Beta Lactams SAR Degradation.pptxEzetimibe and Other Beta Lactams SAR Degradation.pptx
Ezetimibe and Other Beta Lactams SAR Degradation.pptx
 
Nos2003 conner
Nos2003 connerNos2003 conner
Nos2003 conner
 
FUNCTIONAL GROUP MODIFICATION : Medicinal Chemistry
FUNCTIONAL GROUP MODIFICATION : Medicinal ChemistryFUNCTIONAL GROUP MODIFICATION : Medicinal Chemistry
FUNCTIONAL GROUP MODIFICATION : Medicinal Chemistry
 
Structural Studies of Human GBE1 and Relevance to APBD
Structural Studies of Human GBE1 and Relevance to APBDStructural Studies of Human GBE1 and Relevance to APBD
Structural Studies of Human GBE1 and Relevance to APBD
 
paper1-published
paper1-publishedpaper1-published
paper1-published
 
Drug design
Drug designDrug design
Drug design
 
ASBMB Poster_16April2014_Draft5
ASBMB Poster_16April2014_Draft5ASBMB Poster_16April2014_Draft5
ASBMB Poster_16April2014_Draft5
 
BIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUK
BIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUKBIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUK
BIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUK
 
Enzymes
EnzymesEnzymes
Enzymes
 
7.6 enzymes
7.6 enzymes7.6 enzymes
7.6 enzymes
 

Recently uploaded

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 

Recently uploaded (20)

Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 

Structure activity relationship 6

  • 2.  Structure  Activity  SAR (Discussion/Elaboration) Contents 2
  • 3. 3 Crude drug Structure Ligand bindingReceptor Biological response
  • 4. 4 CHEMICAL STRUCTURE  A chemical structure includes molecular geometry, electronic structure, and crystal structure of a molecule. BIOLOGICALACTIVITY  Biological activity is an expression describing the beneficial or adverse effects of a drug on living matter.
  • 5. 5 STRUCTURE ACTIVITY RELATIONSHIP  The relationship between the chemical or 3D structure of a molecule and its biological activity. Enables the determination of the chemical groups responsible for evoking a target biological effect in the organism.
  • 6. 6 WHY SAR Exist? • The interaction of the drug molecule with protein depends on its chemical structure NEED OF SAR STUDY • A study of the structure–activity relationship is mainly done by lead molecule. • It is used to determine pharmacophore, unwanted side effects • To develop a new drug that has increased activity.
  • 7. 7 Cont.….. • To determine some different activity from an existing drug • To fewer unwanted side effects • To know the changes in pharmacological properties by performing minor changes in the drug molecule
  • 10. 10 Camptothecin (CPT) WALL & WANI in early Sixties Camptotheca cuminata,Tree of Joy, Love Quinolino alkaloid Pentacyclic ring structure
  • 11. 11 STRUCTURE OF CPT WITH IUPAC NAME
  • 12. 12 A B C D E Rings A–D are essential for activity. Saturation of ring B< activity necessary for activity essential for activity, S N inactive D-ring pyridone is required for anti tumor activity.  Modifications in rings A, B are well tolerated The stereochemistry at C-20 is very crucial as 20(S) hydroxyl is active, 20(R) inactive modifications at the C , D rings led to complete loss of cytotoxicity.
  • 13. 13 Modification in rings A,B Topotecan Irinotecan
  • 14. 14 Modification in rings C,D  In general, modifications at the C and D rings of camptothecin led to complete loss of cytotoxicity.  If we see these rings, the only positions available for modifications are C-5, C-14 and C-17. Several derivatives have been reported either with less activity or with loss of activity.
  • 15. 15 Modification in ring E  The α- hydroxyl lactone system of ring E has been found to be important for the inhibition of the topoisomerase enzyme as well as for in vivo potency  Derivatives having a lactam group instead of a lactone, were devoid of topoisomerase inhibitor activity.
  • 16. 16
  • 17. 17 TAXOL Taxol, paclitaxel, trade name taxol, by Dr. WALL and Dr. WANI Complex polyoxygenated diterpenoid Pacific yew, Taxus brevifolia basic [9.3.1.0] Pentadecane, tetracyclic ring system. N-benzoyl-b-phenyl isoserine side chain, at the C-13 hydroxyl as an ester linkage.
  • 18. 18 STRUCTURE OF TAXOL WITH IUPAC NAME
  • 19. 19 Oxitane ring essential Ester, Amino ester,epimer,deoxy = active Reduction enhance activity Removal of acetyl < activity Phenyl isoserine chain essential for activity N-acyl group, required Aryl group, essential Free OH active in both(in vivo, in vitro) Ester only in vivo The C-3’aryl group is required for better activity, methyl group, activity is reduced19- fold. northern and southern hemispheres. modifications in the southern hemisphere are strictly forbidden while in the northern hemisphere are allowed
  • 20. 20 C-13 SIDE CHAIN  C-13 side chain is essentially required for anticancer activity. The C-2’-hydroxyl is important for activity.  When this hydroxyl is protected, activity is reduced to a great extent and if the protection is made with a labile group it shows similar activity in vivo, while no activity is shown in in vitro testing
  • 22. 22
  • 23. 23 The main structural features of flavonoids required for efficient radical scavenging could be summarized as i. An ortho-dihydroxy (catechol) structure in the B ring, for electron delocalization
  • 24. 24  2,3-double bond in conjugation with a 4-oxo function in the C ring provides electron delocalization from the B ring
  • 25. 25  Hydroxyl groups at positions 3 and 5 provide hydrogen bonding to the Oxo group